Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Coronary artery bypass surgery, also known as coronary artery bypass graft (CABG) surgery, and colloquially heart bypass or bypass surgery, is a surgical procedure to restore normal blood flow to an obstructed coronary artery.
Market Analysis and Insights: Global Coronary Artery Bypass Grafts (CABG) Market
Due to the COVID-19 pandemic, the global Coronary Artery Bypass Grafts (CABG) market size is estimated to be worth US$ 128.5 million in 2021 and is forecast to a readjusted size of US$ 128.5 million by 2028 with a CAGR of 5.2% during the review period. Fully considering the economic change by this health crisis, by Type accounting for % of the Coronary Artery Bypass Grafts (CABG) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Type segment is altered to an % CAGR throughout this forecast period.
Global Coronary Artery Bypass Grafts (CABG) key players include Medtronic, Getinge Group, LivaNova, Terumo, Boston Scientific, etc. Global top five manufacturers hold a share about 65%.
North America is the largest market, with a share over 35%, followed by Europe and Asia-Pacific, both have a share about 55 percent.
In terms of product, Saphenous Vein Grafts is the largest segment, with a share about 70%. And in terms of application, the largest application is Traditional CABG, followed by Nontraditional CABG.
Global Coronary Artery Bypass Grafts (CABG) Scope and Market Size
The global Coronary Artery Bypass Grafts (CABG) market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Coronary Artery Bypass Grafts (CABG) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
Segment by Type
Saphenous Vein Grafts
Internal Thoracic Artery Grafts
Other
Segment by Application
Traditional CABG
Nontraditional CABG
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Medtronic
Getinge Group
LivaNova
Terumo
Boston Scientific
Stryker
Edwards Lifesciences
Genesee Biomedical
Karl Storz GmbH
Market Analysis and Insights: Global Coronary Artery Bypass Grafts (CABG) Market
Due to the COVID-19 pandemic, the global Coronary Artery Bypass Grafts (CABG) market size is estimated to be worth US$ 128.5 million in 2021 and is forecast to a readjusted size of US$ 128.5 million by 2028 with a CAGR of 5.2% during the review period. Fully considering the economic change by this health crisis, by Type accounting for % of the Coronary Artery Bypass Grafts (CABG) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Type segment is altered to an % CAGR throughout this forecast period.
Global Coronary Artery Bypass Grafts (CABG) key players include Medtronic, Getinge Group, LivaNova, Terumo, Boston Scientific, etc. Global top five manufacturers hold a share about 65%.
North America is the largest market, with a share over 35%, followed by Europe and Asia-Pacific, both have a share about 55 percent.
In terms of product, Saphenous Vein Grafts is the largest segment, with a share about 70%. And in terms of application, the largest application is Traditional CABG, followed by Nontraditional CABG.
Global Coronary Artery Bypass Grafts (CABG) Scope and Market Size
The global Coronary Artery Bypass Grafts (CABG) market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Coronary Artery Bypass Grafts (CABG) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
Segment by Type
Saphenous Vein Grafts
Internal Thoracic Artery Grafts
Other
Segment by Application
Traditional CABG
Nontraditional CABG
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Medtronic
Getinge Group
LivaNova
Terumo
Boston Scientific
Stryker
Edwards Lifesciences
Genesee Biomedical
Karl Storz GmbH
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
